Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) reported Q4 revenue for the quarter at $27.91 million versus the consensus estimate of $24.65 million.

For earnings history and earnings-related data on Mirum Pharmaceuticals, Inc. (MIRM) click here.